Developer docs
API playgroundTry for free, no card

Search company profiles

Chemence

Full company profile

uuid000alzx

Namestring
Chemence
Legal namestring
Chemence Inc. (US) / Chemence Ltd (UK)
Websiteurl
chemence.com
Company typeenum
Private
Founded yearint
1983
Descriptiontext

Chemence is a privately held specialty chemicals company founded in the United Kingdom in 1983 by Hugh V. Cooke and expanded to the United States in 1989, currently headquartered in Alpharetta, Georgia with wholly owned entities in the UK, Poland, and Spain. The company is structured around polymerizable chemistry, technologies that convert liquids into solids through curing mechanisms including cyanoacrylates, anaerobic compounds, polyurethane hot melts, liquid photopolymers, and UV curing resins. It operates one of the largest adhesives manufacturing facilities in North America (a 100,000 sq ft plant in Georgia, established 1993) alongside a 30,000 sq ft R&D Center of Excellence, and runs sales offices in South Korea, China, and Poland serving customers globally. Ownership and leadership remain founder-family controlled, with James Cooke as CEO and Jeff Roberson as President of the medical subsidiary.

The company monetizes its chemistry through six distinct business units: Chemence Medical (FDA-cleared topical skin adhesives including Exofin Fusion and the Exofin Precision Pen, sold to hospitals and medical centers globally), Industrial/KRYLEX (cyanoacrylates, anaerobic sealants, polyurethane hot melts, and UV curing resins for automotive, electronics, and electric vehicle OEMs), Consumer (LiquidSkin liquid bandage and private label partnerships with retail distributors across cosmetic, DIY repair, and craft channels), Graphics/KRYLEX (photopolymer printing plates, high-definition imagers, GENESYS automation software, and KwikMount composite substrate), Chemence Cosmetics, and VIS/Anaseal for visibility and installation solutions. Named enterprise customers span Caterpillar, Chrysler, Ford, General Motors, Mack Truck, Frigidaire, Johnson Controls, Phillips Electronics, and Zenith, indicating deep penetration into Tier 1 and Tier 2 OEM supply chains.

Revenue is generated primarily through one-time hardware and consumable sales (medical devices, industrial adhesives, photopolymer resins, printing equipment) supplemented by private label and licensing-style partnerships with retail distributors. Chemence Medical derives its market access from a layered regulatory moat including FDA 510(k) clearances, EU MDR CE Mark certification, MDSAP certification across five jurisdictions, and ISO 13485, while industrial operations carry ISO 9001, ISO 14001, and ISO 45001 certifications. Distribution is sales-led and direct: medical products move through the Chemence Medical sales organization to hospitals, industrial products through direct OEM supply relationships and resellers, and consumer products through private label partnerships. Recent strategic emphasis has shifted toward regulatory-driven international expansion of the medical franchise, electric vehicle and electronics adjacency via the KRYLEX line, and proprietary software-enabled graphics workflows.

Short descriptiontext

Chemence is a privately held specialty chemicals company that develops and manufactures polymerizable adhesives (cyanoacrylates, anaerobic sealants, photopolymers, UV curing resins) for medical, industrial, consumer, graphics, and cosmetics markets, supplying hospitals, OEMs, and retail distributors globally from facilities in the US and UK.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersAlpharetta, United States
HQ citystring
Alpharetta
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices6 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
specialty chemical adhesives, medical wound closure, industrial sealants, photopolymer printing plates, cyanoacrylate adhesives
Industry1 code
PRIMARYIMAEABAA
Adhesives & Sealants Chemicals
NAICS code2 codes
  • Adhesive Manufacturing32552
  • Paint, Coating, and Adhesive Manufacturing3255
SIC code2 codes
  • Adhesives & Sealants2891
  • Plastic Materials, Synth Resins & Nonvulcan Elastomers2821
Product category
Specialty Chemical Adhesives and Sealants
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Medical Adhesives and Devices
TypeHardware Sales
Description

Manufacture and distribution of adhesive-based medical devices including Exofin skin closure systems and precision pen applicators sold to hospitals and medical centers worldwide. Revenue generated through product sales with regulatory certifications (FDA, EU MDR, MDSAP) enabling global market access.

2Industrial and Consumer Adhesives
TypeOne Time License
Description

Sale of specialty adhesives including cyanoacrylates, anaerobic sealants, polyurethane hot melts, and UV curing resins to industrial manufacturers and consumer markets. Includes branded products and private label partnerships.

chemence.com
3Private Label Partnerships
TypeLicensing Royalties
Description

Partnership with retail distributors to develop products in cosmetic, DIY repair, and craft industries, creating branded products for consumer markets.

chemence.com
4KRYLEX Graphics Products
TypeHardware Sales
Description

Photopolymer resins, imaging solutions, processing equipment, and specialty substrates for printing and graphics industry. Includes GENESYS automation software and refurbished equipment services.

chemence.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1Exofin®
Description

Medical skin closure and wound care adhesive products including Exofin Fusion® skin closure system and Exofin Precision Pen for wound closure

chemence.com
+5 more records
Core offering1 text field

Chemence develops, manufactures, and sells specialty polymerizable chemistry-based adhesives and sealants across medical, industrial, consumer, cosmetics, and graphics markets. Core offerings include FDA-cleared cyanoacrylate medical devices for wound closure (Exofin Fusion, Exofin Precision Pen), industrial adhesives for automotive and electronics OEMs, KRYLEX photopolymer printing plates and imaging systems, LiquidSkin over-the-counter liquid bandages, and private-label consumer products. The company operates manufacturing in the US and UK and distributes globally through direct sales, OEM supply contracts, and private-label retail partnerships.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 67% reduction in potential damage area due to stress with curved mesh design
+4 more records
Product overview1 text field

Chemence is a specialty chemicals company specializing in polymerizable technology that converts liquids into solids through curing technologies. The company operates across multiple business units: Chemence Medical (FDA-cleared wound closure devices including Exofin Fusion and Exofin Precision Pen), Consumer Products (LiquidSkin liquid bandage and private label products), Industrial/KRYLEX (adhesives for electronics, medical devices, and electric vehicles), Graphics/KRYLEX (photopolymer printing plates, imagers, and GENESYS automation software), and Anaseal VIS (printing solutions). Product portfolio spans cyanoacrylate adhesives, anaerobic sealants, polyurethane hot melts, UV light cure adhesives, and liquid photopolymers. The company maintains manufacturing facilities in the US and UK with global sales reach.

Product and service6 records
1Exofin Fusion Skin Closure System
CategoryMedical Device
Description

A medical device combining a self-adhering flexible mesh strip with fast-curing 2-octyl cyanoacrylate topical adhesive that closes and seals incisions while forming an immediate microbial barrier. Designed for hospitals, surgical centers, and healthcare providers for wound closure applications.

2Exofin Precision Pen
CategoryMedical Device
Description

A pen-style applicator medical device for wound closure featuring an adjustable tip supporting micro-bristle brush, inverted brush, and angle precision tip application methods, with pressure-controlled variable adhesive flow. Provides 14-day microbial barrier and is intended for medical providers requiring precision application across varied wound sizes and locations.

3Exofin High Viscosity Tissue Adhesive
CategoryMedical Device
Description

A topical skin adhesive with the highest viscosity formulation in the industry, designed for medical applications including wound closure and tissue bonding.

4LiquidSkin Liquid Bandage
CategoryConsumer Healthcare Product
Description

An over-the-counter liquid bandage made with n-butyl medical-grade cyanoacrylate that provides waterproof, flexible wound protection lasting 3-5 days per application. Sold through retail channels for individual consumer wound care.

5KRYLEX Photopolymer Resins
CategoryIndustrial Printing Product
Description

Reclaimable photopolymer resins processed with aqueous formulation technology for sustainable printing plate manufacturing, with accelerated processing times and printing endurance. Used by printing plate manufacturers and corrugated packaging converters.

6KRYLEX Imaging Solutions
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Idea|Span
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-03-03
Description

Idea|Span of Atlanta, Georgia partnered with Chemence to design the 30,000 sq.ft. Chemence Center of Excellence R&D facility. The collaborative open space design was intended to maximize daily interactions among researchers and support team-based innovation.

chemence.com
Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Arkema-owned specialty adhesives and sealants business serving industrial, construction and consumer markets globally; comparable product range to Chemence with broader geographic footprint.

23M
TypeBroad incumbent
Description

Diversified industrial and consumer adhesives/materials giant; previously acquired Ritelok technology originally developed in-house at Chemence, making it a direct technology and channel comparable across industrial and consumer adhesive lines.

TypeDirect peer
Description

US medical cyanoacrylate adhesive company with topical skin closure and wound care products (LiquiFix, SurgiSeal) that directly compete with Chemence Medical's Exofin line in clinical settings.

TypeBroad incumbent
Description

Pressure-sensitive adhesive and label materials major serving industrial and consumer markets; comparable in specialty adhesives chemistry and consumer/retail channel presence, though focused on labels and tapes.

TypeDirect peer
Description

Specialty cyanoacrylate and anaerobic adhesive manufacturer serving industrial OEM customers with comparable chemistry portfolio to Chemence's industrial adhesives and sealants business.

TypeDirect peer
Description

Specialty industrial adhesives manufacturer serving packaging, hygiene, automotive and construction end markets with similar customer verticals to Chemence's industrial adhesives business.

TypeBroad incumbent
Description

Global adhesives leader (Loctite, Pattex, Bonderite) with broad industrial, consumer and electronics adhesive portfolios; directly comparable to Chemence's diversified adhesive offering but at vastly larger scale.

TypeBroad incumbent
Description

Swiss specialty chemicals company focused on construction and industrial bonding, sealing and reinforcing; comparable chemistry footprint and automotive/OEM customer overlap with Chemence's industrial segment.

TypeRegional player
Description

Japanese chemical manufacturer producing cyanoacrylate adhesives under the Aron Alpha brand; comparable technology platform and product chemistry to Chemence, though primarily serving Asia-Pacific markets.

TypeDirect peer
Description

UK-listed medical wound closure company with LiquiBand cyanoacrylate topical skin adhesives that compete head-to-head with Chemence's Exofin Fusion and Exofin Precision Pen products in hospitals and surgical centers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries11 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance8 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Chemence

Specialty Chemical Adhesives and Sealantschemence.com

Chemence is a privately held specialty chemicals company that develops and manufactures polymerizable adhesives (cyanoacrylates, anaerobic sealants, photopolymers, UV curing resins) for medical, industrial, consumer, graphics, and cosmetics markets, supplying hospitals, OEMs, and retail distributors globally from facilities in the US and UK.

What Chemence does

Chemence is a privately held specialty chemicals company founded in the United Kingdom in 1983 by Hugh V. Cooke and expanded to the United States in 1989, currently headquartered in Alpharetta, Georgia with wholly owned entities in the UK, Poland, and Spain. The company is structured around polymerizable chemistry, technologies that convert liquids into solids through curing mechanisms including cyanoacrylates, anaerobic compounds, polyurethane hot melts, liquid photopolymers, and UV curing resins. It operates one of the largest adhesives manufacturing facilities in North America (a 100,000 sq ft plant in Georgia, established 1993) alongside a 30,000 sq ft R&D Center of Excellence, and runs sales offices in South Korea, China, and Poland serving customers globally. Ownership and leadership remain founder-family controlled, with James Cooke as CEO and Jeff Roberson as President of the medical subsidiary.

The company monetizes its chemistry through six distinct business units: Chemence Medical (FDA-cleared topical skin adhesives including Exofin Fusion and the Exofin Precision Pen, sold to hospitals and medical centers globally), Industrial/KRYLEX (cyanoacrylates, anaerobic sealants, polyurethane hot melts, and UV curing resins for automotive, electronics, and electric vehicle OEMs), Consumer (LiquidSkin liquid bandage and private label partnerships with retail distributors across cosmetic, DIY repair, and craft channels), Graphics/KRYLEX (photopolymer printing plates, high-definition imagers, GENESYS automation software, and KwikMount composite substrate), Chemence Cosmetics, and VIS/Anaseal for visibility and installation solutions. Named enterprise customers span Caterpillar, Chrysler, Ford, General Motors, Mack Truck, Frigidaire, Johnson Controls, Phillips Electronics, and Zenith, indicating deep penetration into Tier 1 and Tier 2 OEM supply chains.

Revenue is generated primarily through one-time hardware and consumable sales (medical devices, industrial adhesives, photopolymer resins, printing equipment) supplemented by private label and licensing-style partnerships with retail distributors. Chemence Medical derives its market access from a layered regulatory moat including FDA 510(k) clearances, EU MDR CE Mark certification, MDSAP certification across five jurisdictions, and ISO 13485, while industrial operations carry ISO 9001, ISO 14001, and ISO 45001 certifications. Distribution is sales-led and direct: medical products move through the Chemence Medical sales organization to hospitals, industrial products through direct OEM supply relationships and resellers, and consumer products through private label partnerships. Recent strategic emphasis has shifted toward regulatory-driven international expansion of the medical franchise, electric vehicle and electronics adjacency via the KRYLEX line, and proprietary software-enabled graphics workflows.

Chemence firmographics

Firmographics
Name
Chemence
Legal name
Chemence Inc. (US) / Chemence Ltd (UK)
Website
https://chemence.com
Company type
Private
Founded year
1983
Operating status
Operating
Headcount range
101–250 employees
Short description
Chemence is a privately held specialty chemicals company that develops and manufactures polymerizable adhesives (cyanoacrylates, anaerobic sealants, photopolymers, UV curing resins) for medical, industrial, consumer, graphics, and cosmetics markets, supplying hospitals, OEMs, and retail distributors globally from facilities in the US and UK.
Ownership category
akta.pro rank

Chemence industry classification

Industry
Product category
Specialty Chemical Adhesives and Sealants
NAICS
Adhesive Manufacturing (32552), Paint, Coating, and Adhesive Manufacturing (3255)
SIC
Adhesives & Sealants (2891), Plastic Materials, Synth Resins & Nonvulcan Elastomers (2821)
akta.pro industry
PRIMARYIMAEABAA
Adhesives & Sealants Chemicals

Keywords

  • Specialty chemical adhesives
  • Medical wound closure
  • Industrial sealants
  • Photopolymer printing plates
  • Cyanoacrylate adhesives

Where Chemence is headquartered

Location

Headquarters

HQ city
Alpharetta
HQ country
United States
HQ region
North America

Offices6 records

Markets served

Chemence business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Adhesives and Devices: Manufacture and distribution of adhesive-based medical devices including Exofin skin closure systems and precision pen applicators sold to hospitals and medical centers worldwide. Revenue generated through product sales with regulatory certifications (FDA, EU MDR, MDSAP) enabling global market access.
  2. Industrial and Consumer Adhesives: Sale of specialty adhesives including cyanoacrylates, anaerobic sealants, polyurethane hot melts, and UV curing resins to industrial manufacturers and consumer markets. Includes branded products and private label partnerships.
  3. Private Label Partnerships: Partnership with retail distributors to develop products in cosmetic, DIY repair, and craft industries, creating branded products for consumer markets.
  4. KRYLEX Graphics Products: Photopolymer resins, imaging solutions, processing equipment, and specialty substrates for printing and graphics industry. Includes GENESYS automation software and refurbished equipment services.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Chemence product offering

Product offering

Core offering

Chemence develops, manufactures, and sells specialty polymerizable chemistry-based adhesives and sealants across medical, industrial, consumer, cosmetics, and graphics markets. Core offerings include FDA-cleared cyanoacrylate medical devices for wound closure (Exofin Fusion, Exofin Precision Pen), industrial adhesives for automotive and electronics OEMs, KRYLEX photopolymer printing plates and imaging systems, LiquidSkin over-the-counter liquid bandages, and private-label consumer products. The company operates manufacturing in the US and UK and distributes globally through direct sales, OEM supply contracts, and private-label retail partnerships.

Product overview

Chemence is a specialty chemicals company specializing in polymerizable technology that converts liquids into solids through curing technologies. The company operates across multiple business units: Chemence Medical (FDA-cleared wound closure devices including Exofin Fusion and Exofin Precision Pen), Consumer Products (LiquidSkin liquid bandage and private label products), Industrial/KRYLEX (adhesives for electronics, medical devices, and electric vehicles), Graphics/KRYLEX (photopolymer printing plates, imagers, and GENESYS automation software), and Anaseal VIS (printing solutions). Product portfolio spans cyanoacrylate adhesives, anaerobic sealants, polyurethane hot melts, UV light cure adhesives, and liquid photopolymers. The company maintains manufacturing facilities in the US and UK with global sales reach.

Differentiator

Problem solved

Functional benefit

Brands

  • Exofin®: Medical skin closure and wound care adhesive products including Exofin Fusion® skin closure system and Exofin Precision Pen for wound closure
  • LiquidSkin®
  • KRYLEX®
  • Anaseal®
  • GENESYS™
  • KwikMount

Products and services

  • Exofin Fusion Skin Closure System A medical device combining a self-adhering flexible mesh strip with fast-curing 2-octyl cyanoacrylate topical adhesive that closes and seals incisions while forming an immediate microbial barrier. Designed for hospitals, surgical centers, and healthcare providers for wound closure applications.
  • Exofin Precision Pen A pen-style applicator medical device for wound closure featuring an adjustable tip supporting micro-bristle brush, inverted brush, and angle precision tip application methods, with pressure-controlled variable adhesive flow. Provides 14-day microbial barrier and is intended for medical providers requiring precision application across varied wound sizes and locations.
  • Exofin High Viscosity Tissue Adhesive A topical skin adhesive with the highest viscosity formulation in the industry, designed for medical applications including wound closure and tissue bonding.
  • LiquidSkin Liquid Bandage An over-the-counter liquid bandage made with n-butyl medical-grade cyanoacrylate that provides waterproof, flexible wound protection lasting 3-5 days per application. Sold through retail channels for individual consumer wound care.
  • KRYLEX Photopolymer Resins Reclaimable photopolymer resins processed with aqueous formulation technology for sustainable printing plate manufacturing, with accelerated processing times and printing endurance. Used by printing plate manufacturers and corrugated packaging converters.
  • KRYLEX Imaging Solutions

Quantifiable outcome

  • 67% reduction in potential damage area due to stress with curved mesh design
  • +4 more outcomes

Companies that use Chemence

Customer profile

Named customers10 records

Segments6 records

Ideal customer profiles5 records

Chemence technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Chemence partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Idea|SpanminorStrategic or Co-development Partner · 3 March 2021Idea|Span of Atlanta, Georgia partnered with Chemence to design the 30,000 sq.ft. Chemence Center of Excellence R&D facility. The collaborative open space design was intended to maximize daily interactions among researchers and support team-based innovation.

Scale indicators6 records

Recent moves10 records

Expansion highlights6 records

Chemence competitors and assessment

Company assessment

Broad incumbents

  • Bostik (Arkema): Arkema-owned specialty adhesives and sealants business serving industrial, construction and consumer markets globally; comparable product range to Chemence with broader geographic footprint.
  • 3M: Diversified industrial and consumer adhesives/materials giant; previously acquired Ritelok technology originally developed in-house at Chemence, making it a direct technology and channel comparable across industrial and consumer adhesive lines.
  • Avery Dennison: Pressure-sensitive adhesive and label materials major serving industrial and consumer markets; comparable in specialty adhesives chemistry and consumer/retail channel presence, though focused on labels and tapes.
  • Henkel: Global adhesives leader (Loctite, Pattex, Bonderite) with broad industrial, consumer and electronics adhesive portfolios; directly comparable to Chemence's diversified adhesive offering but at vastly larger scale.
  • Sika AG: Swiss specialty chemicals company focused on construction and industrial bonding, sealing and reinforcing; comparable chemistry footprint and automotive/OEM customer overlap with Chemence's industrial segment.

Direct peers

  • Adhezion Biomedical: US medical cyanoacrylate adhesive company with topical skin closure and wound care products (LiquiFix, SurgiSeal) that directly compete with Chemence Medical's Exofin line in clinical settings.
  • Permabond Engineering Adhesives: Specialty cyanoacrylate and anaerobic adhesive manufacturer serving industrial OEM customers with comparable chemistry portfolio to Chemence's industrial adhesives and sealants business.
  • H.B. Fuller: Specialty industrial adhesives manufacturer serving packaging, hygiene, automotive and construction end markets with similar customer verticals to Chemence's industrial adhesives business.
  • Advanced Medical Solutions Group: UK-listed medical wound closure company with LiquiBand cyanoacrylate topical skin adhesives that compete head-to-head with Chemence's Exofin Fusion and Exofin Precision Pen products in hospitals and surgical centers.

Regional players

  • Toagosei Co., Ltd. Japanese chemical manufacturer producing cyanoacrylate adhesives under the Aron Alpha brand; comparable technology platform and product chemistry to Chemence, though primarily serving Asia-Pacific markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Chemence compliance and trust

Trust signal

Compliance8 records

Chemence financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Chemence leadership team

Management profile

Number of profiles

Profiles5 records

Chemence subsidiaries and ownership

Company hierarchy

Subsidiaries11 records

Chemence funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Chemence M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Chemence

What does Chemence do?

Chemence develops, manufactures, and sells specialty polymerizable chemistry-based adhesives and sealants across medical, industrial, consumer, cosmetics, and graphics markets. Core offerings include FDA-cleared cyanoacrylate medical devices for wound closure (Exofin Fusion, Exofin Precision Pen), industrial adhesives for automotive and electronics OEMs, KRYLEX photopolymer printing plates and imaging systems, LiquidSkin over-the-counter liquid bandages, and private-label consumer products. The company operates manufacturing in the US and UK and distributes globally through direct sales, OEM supply contracts, and private-label retail partnerships.

Is Chemence a public or private company?

Chemence is a private company. It is classified as family owned and is currently operating.

When was Chemence founded?

Chemence was founded in 1983. It employs 101 to 250 people.

Where is Chemence based?

Chemence is headquartered in Alpharetta, United States, in the North America region.

How does Chemence make money?

Four revenue lines are on record. Medical Adhesives and Devices are the primary driver. The others are industrial and Consumer Adhesives, private Label Partnerships and KRYLEX Graphics Products.

Who are Chemence's main competitors?

Broad incumbents on record are Bostik (Arkema), 3M, Avery Dennison, Henkel and Sika AG. Direct peers are Adhezion Biomedical, Permabond Engineering Adhesives, H.B. Fuller and Advanced Medical Solutions Group. Toagosei Co., Ltd. is listed as a regional player.

Does Chemence have an API?

No public API is recorded for Chemence.

What industry is Chemence in?

Chemence's product category is Specialty Chemical Adhesives and Sealants. Its primary akta.pro industry code is IMAEABAA, Adhesives & Sealants Chemicals. Its NAICS code is 32552 and its SIC code is 2891.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Atlanta Journal-ConstitutionAlpharetta company hit with $58M verdict in fight over consultant’s arrestA Fulton County jury awarded $58 million to Stanford professor James Quinn in a legal battle with Chemence, an Alpharetta medical adhesive company. The verdict includes $12 million in compensation, $5 million in attorney fees, and $41 million in punitive damages. The decision marks a blow in a 15-year entanglement.Business Wire BlogChemence Launches KURA-LOW™ Adhesive Technology Chemistry Platform Driving Paradigm Shift for Consumer Electronic Device Assembly ProcessesChemence, Inc. has launched KURA-LOW™, a new chemistry platform available in select KRYLEX adhesive formulations for consumer electronics device assembly. The technology enables high-performance bonding at cure temperatures as low as 60°C — significantly lower than existing competitive adhesive systems that require higher temperatures or two-component formats. The room temperature-stabilized, one-part pre-mixed adhesive offers stability of 3-5 days to 6 weeks depending on the formula, and targets applications including camera modules, OLED displays, sensors, and wearable electronics.PR NewswireChemence Opens New Research and Development FacilityChemence announced the opening of the Chemence Center of Excellence, a 30,000 sq.ft. research and development facility in Alpharetta, Georgia. The facility houses a team of scientists and engineers supporting adhesive developments in the medical, electronics, and OEM industries, featuring specialized labs for analytical testing, materials testing, environmental conditioning, and applications development. The company plans to expand further into the facility with a second phase that will house several corporate functions.Law360Glue Maker To Pay FTC $1.2M Over 'Made In USA' ClaimsThe Federal Trade Commission settled charges against glue maker Chemence Inc. for deceptive 'Made in USA' claims on its packaging, ordering the company to pay $1.2 million. This is the agency's highest monetary judgment in a 'Made in USA' case.